CME Group (CME) is a publicly traded Financial Services sector company. As of May 20, 2026, CME trades at $291.29 with a market cap of $110.56B and a P/E ratio of 24.74. CME moved -4.05% today. Year to date, CME is +12.12%; over the trailing twelve months it is +8.79%. Its 52-week range spans $213.94 to $329.16. Analyst consensus is neutral with an average price target of $304.20. Rallies surfaces CME's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded CME stock?
Recent politician trading activity in CME includes disclosures from Gilbert Cisneros, Julie Johnson, Julie Johnson, Val Hoyle, and Julie Johnson. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
CME Key Metrics
Key financial metrics for CME
Metric
Value
Price
$291.29
Market Cap
$110.56B
P/E Ratio
24.74
EPS
$11.80
Dividend Yield
1.30%
52-Week High
$329.16
52-Week Low
$213.94
Volume
2.06M
Avg Volume
0
Revenue (TTM)
$6.76B
Net Income
$4.27B
Gross Margin
0.00%
Congressional Trades in CME
Gilbert Cisneros purchase CME on Jan 9, 2026 (amount: $15.00K).
Julie Johnson sale CME on Dec 18, 2025 (amount: $15.00K) for Joint.
Julie Johnson sale CME on Nov 13, 2025 (amount: $15.00K) for Joint.
Val Hoyle sale CME on Sep 23, 2025 (amount: $15.00K) for Spouse.
Julie Johnson purchase CME on Jul 22, 2025 (amount: $15.00K) for Joint.
Recent politician trading activity in CME includes disclosures from Gilbert Cisneros, Julie Johnson, Julie Johnson, Val Hoyle, and Julie Johnson. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in CME?
Yes. Rallies tracks politician and congressional stock disclosures for CME, including reported purchases, sales, dates, owners, and trade amounts when available.
Is CME research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CME. It does not provide personalized investment advice.